Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading Update

11 Nov 2024 07:00

RNS Number : 5909L
Science Group PLC
11 November 2024
 

 

11 November 2024

 

Science Group plc

(the "Company" or "Science Group")

 

Trading Update

 

 

The Group's trading performance for FY24 remains on track to deliver another record year of adjusted operating profit in line with expectations.

 

While not immune to the UK and international political/economic environment, Science Group benefits from the resilience inherent in its portfolio. In that regard, the UK budget on 30 October 2024 increased Employer's National Insurance with an estimated annualised increase to the Group's operating cost base in the order of £0.7 million. The Board will consider how to mitigate this impact during the forthcoming 2025 planning cycle.

 

Science Group retains a very strong balance sheet with significant cash resources. At 31 October 2024, the Group had gross cash of £37.7 million and net funds of £25.6 million, after returning a total of £7.4 million to shareholders in 2024 through the buyback programme and an increased dividend. As announced on 22 October 2024, the operation of the share buyback programme is now delegated to Panmure Liberum.

 

The Group's Term Loan expires in September 2026. In addition, the Group has an undrawn Revolving Credit Facility ("RCF") of £25 million which is available until December 2026. In order to support the Group's corporate strategy, the Board is considering:

 

· Refinancing the Term Loan for a new 10 year period, secured on the Group's freehold properties, and

· Renewing the RCF on a new 5 year term and increasing the facility to £30 million with an additional £10 million accordion option.

 

Negotiations are progressing well and term sheets have been agreed. Legal documentation is anticipated to take several weeks. If concluded on satisfactory terms, these new, increased facilities with extended commitment periods, combined with the Group's existing cash resources, would strengthen Science Group's ability to continue to consider corporate opportunities which may arise.

 

 

- Ends -

 

 

For further information:

Science Group plc

Martyn Ratcliffe, Executive Chair

Tel: +44 (0) 1223 875 200

Jon Brett, Finance Director

www.sciencegroup.com  

Cannacord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

Panmure Liberum Capital Limited (Joint Broker)

Max Jones, John More

Tel: +44 (0) 20 3100 2000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWANRSVUARAA
Date   Source Headline
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:01 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTreasury shares issued
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:01 amRNSTransaction in Own Shares
27th May 20267:00 amRNSIssue of share options and PDMR dealing
22nd May 20267:00 amRNSTreasury Shares Issued
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:05 pmRNSResult of Annual General Meeting
20th May 20267:01 amRNSAGM Trading Update and Capital Allocation
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:01 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTreasury Shares Issued
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:01 amRNSNotice of Annual General Meeting
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTreasury Shares Issued
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.